english.prescrire.org > Annual Prescrire Awards > The Prescrire Awards for 2025 > Prescrire Information Awards for 2025 > Prescrire Information Awards for 2025 > About the Prescrire Drug Awards for 2025

The Prescrire Awards for 2025

Prescrire Information Awards for 2025

The Prescrire Information Awards for 2025
About the Prescrire Drug Awards for 2025

Les Palmarès Prescrire The 2025 Prescrire Drug Awards are based on the analyses published in the Marketing Authorisations section of our French edition in 2025.

• The annual Prescrire Awards are granted in total independence by the Prescrire Editorial staff

Every month, in the Marketing Authorisations section, Prescrire's Editorial Staff points out which of the multitude of products or indications newly authorised in Europe or in France are worth adding to healthcare professionals' list of useful treatment options, and which are to be avoided. These conclusions are based on systematic analyses of the relevant evaluation data available on new drugs, new indications for drugs already authorised in a different clinical situation, and new pharmaceutical forms or new dose strengths of existing drugs. We also regularly re-examine the harm-benefit balance of drugs we have previously analysed, when new relevant data come to light.

Prescrire's multidisciplinary team has been conducting and publishing drug analyses for 45 years, free from the influence of any companies or public agencies involved in the healthcare sector. Prescrire is funded exclusively by its subscribers, receives no grants or subsidies of any kind, carries no paid advertising, and has no shareholders.

The 2025 Prescrire Drug Awards are based on the analyses published in the Marketing Authorisations section of our French edition in 2025. These awards recognise products that represent a therapeutic advance, in that they offer better efficacy than existing treatments, provoke less frequent or less severe adverse effects (provided they also have similar efficacy), or enable a useful drug to be used more safely or easily.

See: How we work

For more information:

  • "A systematic, collective editorial process" > FREE
  • "Prescrire's ratings for new drugs and new indications" > FREE

Le Palmarès de l'information
 The Prescrire Drug Awards for 2025


Download the full article:

Télécharger
 FREE  "The Prescrire Awards for 2025" Prescrire Int 2026; 35 (281): 134-138. FREE.

 

Back to "The Prescrire Awards for 2025"

©Prescrire May 2026      

Filet

Enjoy full access to Prescrire International, and support independent information